Sara C. Wen - Publications

The prognostic potential of an immunology score in patients treated with curative surgery for non-small cell lung cancer.

Journal: Journal of cancer research and clinical oncology

Published: April 15, 2026

Prognostic performance of a novel multiplex circulating tumor DNA assay for lung cancer outcomes.

Journal: Therapeutic advances in medical oncology

Published: April 08, 2026

A multi-reader multi-case framework for evaluating the decision impact of emerging diagnostic tests for lung cancer.

Journal: Scientific reports

Published: March 24, 2026

Prognostic significance of circulating tumor DNA as a baseline or dynamic factor in advanced NSCLC without oncogenic drivers: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: November 27, 2025

The prognostic value of methylated ctDNA, soluble PD-L1, and NK-cell activity on the risk of relapse after curative radiotherapy of non-small cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 21, 2025

Response to Letter to the Editor.

Journal: Clinical lung cancer

Published: August 20, 2025

Development and validation of a methylation-specific droplet digital PCR multiplex for lung cancer detection.

Journal: Scientific reports

Published: May 15, 2025

Educational attainment and employment status in lung cancer patients: a nationwide study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 30, 2025

Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlag.

Journal: Clinical lung cancer

Published: March 20, 2025

Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA.

Journal: International journal of molecular sciences

Published: March 08, 2024

Methylated Cell-Free Tumor DNA in Sputum as a Tool for Diagnosing Lung Cancer-A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: December 31, 2023

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.

Journal: Scientific reports

Published: December 08, 2023